青光眼视力结局与眼科诊疗利用的种族差异:IRIS登记分析
基于IRIS登记库的回顾性队列研究纳入996,297例青光眼患者,评估2015年至2020年不同种族和族裔的视力结局与诊疗利用差异。与非西班牙裔白人眼相比,黑人和西班牙裔眼视杯视盘比进展、视力差及青光眼滤过手术的调整比值比更高,且眼科检查与OCT利用更少。美国原住民患者视力差风险更高且多项监测利用更少。
要点
- 黑人眼视杯视盘比进展OR=1.12、视力差OR=1.26、青光眼滤过手术RR=1.47,均高于白人眼。
- 西班牙裔眼视杯视盘比进展OR=1.28、视力差OR=1.26、低视力诊断OR=1.18,均高于白人眼。
- 黑人和西班牙裔患者眼科检查与OCT利用更少,黑人患者住院/急诊就诊RR=1.64高于白人。
核心结论
- 美国眼科诊疗存在显著种族差异,黑人、西班牙裔和美国原住民患者视力结局更差且疾病监测更少。
- 作者认为这些种族和族裔少数群体中青光眼可能治疗不足,增加青光眼相关视力丧失风险。
研究设计与样本
- 回顾性队列研究,基于美国IRIS登记库(Intelligent Research in Sight)的人群数据。
- 纳入标准为2015年1月1日前至少6个月有至少一个青光眼诊断代码,且2015年有至少一次眼科检查、视野、OCT或眼科相关住院/急诊代码。
- 采用多变量逻辑回归和负二项回归模型评估2015年1月1日至2020年1月1日期间按种族和族裔划分的视力与利用结局。
- 共纳入996,297例患者,其中非西班牙裔白人73%、非西班牙裔黑人15%、西班牙裔9%、亚洲/太平洋岛民3%、美国原住民/阿拉斯加原住民0.3%。
主要发现
- 黑人眼视杯视盘比进展OR=1.12(95%CI 1.08-1.17)、视力差OR=1.26(95%CI 1.22-1.29)、青光眼滤过手术RR=1.47(95%CI 1.42-1.51),均高于白人眼。
- 西班牙裔眼视杯视盘比进展OR=1.28(95%CI 1.22-1.34)、视力差OR=1.26(95%CI 1.22-1.31)、青光眼滤过手术RR=1.13(95%CI 1.09-1.18)、低视力诊断OR=1.18(95%CI 1.07-1.30),均高于白人眼。
- 黑人患者眼科检查RR=0.94(95%CI 0.94-0.95)、OCT RR=0.86(95%CI 0.85-0.86),西班牙裔患者眼科检查RR=0.99(95%CI 0.99-0.99)、OCT RR=0.97(95%CI 0.96-0.98),均低于白人患者。
- 黑人患者住院/急诊就诊RR=1.64(95%CI 1.37-1.96),高于白人患者。
- 美国原住民患者视力差OR=1.17(95%CI 1.01-1.36)高于白人患者,门诊就诊RR=0.89(95%CI 0.86-0.91)、OCT RR=0.85(95%CI 0.82-0.89)、视野RR=0.91(95%CI 0.88-0.94)、激光/手术RR=0.87(95%CI 0.79-0.96)均低于白人患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate racial disparities in vision outcomes and eye care utilization among glaucoma patients. DESIGN: Retrospective cohort study. METHODS: In this population-based IRIS Registry (Intelligent Research in Sight) study, we included patients with minimum one diagnosis code for glaucoma at least 6 months prior to January 1, 2015 and at least one eye exam, visual field (VF), optical coherence tomography (OCT), or eye-related inpatient or emergency department (ED) code in 2015. Multivariable logistic and negative binomial regression models were used to assess vision and utilization outcomes, respectively, across race and ethnicity from January 1, 2015 to January 1, 2020. Vision outcomes included cup-to-disc ratio (CDR) progression > 0.80, poor vision (visual acuity 20/200 or worse), low vision codes, and need for glaucoma filtering surgery. Utilization outcomes included outpatient eye exams, OCTs, VFs, inpatient/ED encounters, and lasers/surgeries. RESULTS: Among 996,297 patients, 73% were non-Hispanic White, 15% non-Hispanic Black, 9% Hispanic, 3% Asian/Pacific Islander, and 0.3% Native American/Alaska Native. Compared to White eyes, Black and Hispanic eyes had higher adjusted odds of CDR progression (odds ratio [OR] = 1.12, 95% confidence interval [CI] = 1.08-1.17; OR = 1.28, 95% CI = 1.22-1.34), poor vision (OR = 1.26, 95% CI = 1.22-1.29; OR = 1.26, 95% CI = 1.22-1.31), glaucoma filtering surgery (rate ratio (RR) = 1.47, 95% CI = 1.42-1.51; RR = 1.13, 95% CI = 1.09-1.18). Hispanic eyes also had increased odds of low vision diagnoses (Hispanic OR = 1.18, 95% CI = 1.07-1.30). Black and Hispanic patients were less likely to have eye exams (RR = 0.94, 95% CI = 0.94-0.95; RR = 0.99, 95% CI = 0.99-0.99) and OCTs (RR = 0.86, 95% CI = 0.85-0.86; RR = 0.97, 95% CI = 0.96-0.98), yet Black patients had higher odds of inpatient/ED encounters (RR = 1.64, 95% CI = 1.37-1.96) compared to White patients. Native American patients were more likely to have poor vision (OR = 1.17, 95% CI = 1.01-1.36) and less likely to have outpatient visits (RR = 0.89, 95% CI = 0.86-0.91), OCTs (RR = 0.85, 95% CI = 0.82-0.89), visual fields (RR = 0.91, 95% CI = 0.88-0.94) or lasers/surgeries (RR = 0.87, 95% CI = 0.79-0.96) compared to White patients. CONCLUSIONS: We found that significant disparities in US eye care exist with Black, Hispanic, and Native American patients having worse vision outcomes and less disease monitoring. Glaucoma may be undertreated in these racial and ethnic minority groups, increasing risk for glaucoma-related vision loss.
引用
- Ciociola EC, Sekimitsu S, Smith S, et al. Racial Disparities in Glaucoma Vision Outcomes and Eye Care Utilization: An IRIS Registry Analysis. Am J Ophthalmol. 2024. PMID: 38548127. doi:10.1016/j.ajo.2024.03.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。